Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Carolyn Atchison"'
Publikováno v:
The American journal of managed care. 23
Parkinson's disease (PD) is a progressive neurodegenerative disease associated with a decrease in the neurotransmitter dopamine and characterized by the cardinal motor hallmarks of resting tremor, rigidity, bradykinesia/akinesia, and postural instabi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f67031dbd0562ca2fe413f1cd77f6cc0
https://pubmed.ncbi.nlm.nih.gov/28715903
https://pubmed.ncbi.nlm.nih.gov/28715903
Autor:
Peter Slasor, Karen Chung, Aftab Mahmood, Hassan Ghazal, Rachel Wei, Joseph J. Pinzone, Carolyn Atchison, Mehool Patel, Peter Suenaert, Marsha G. Fink
Publikováno v:
Community Oncology. 9:148-157
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0c6183249162facfeb72fbcea0b77a53
https://doi.org/10.1016/j.cmonc.2012.02.015
https://doi.org/10.1016/j.cmonc.2012.02.015
Autor:
Ada Braun, Ira Jacobs, Arthur P. Staddon, Javier Martin-Broto, Yi Qian, Carolyn Atchison, Paul Glare, Charles S. Cleeland, Amy Feng, Jacob Engellau, Martin Dominkus, Kristin N. Ganjoo, Karen Chung, Keith M. Skubitz, Ronald H. Blum
Publikováno v:
Acta oncologica (Stockholm, Sweden). 53(9)
Giant cell tumor of bone (GCTB) is an aggressive primary osteolytic tumor. GCTB often involves the epiphysis, usually causing substantial pain and functional disability. Denosumab, a fully human monoclonal antibody against receptor activator of nucle
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c1fb5db75c90b609ed9cfb057773e1b
https://pubmed.ncbi.nlm.nih.gov/24834795
https://pubmed.ncbi.nlm.nih.gov/24834795
Publikováno v:
The Canadian Journal of Hospital Pharmacy. 62
Background: As demand for cancer treatment grows, and newer, more expensive drugs become available, public payers in Canada are finding it increasingly difficult to fund the full range of available cancer drugs. Objective: To determine the extent of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::29ffa7f1c4d010848b2e7be6cef4feec
https://doi.org/10.4212/cjhp.v62i3.795
https://doi.org/10.4212/cjhp.v62i3.795
Autor:
Andrew Worsfold, Carolyn Atchison, Kristina S Chen, Helen Collins, Jorge Arellano, Alex Rider
Publikováno v:
Journal of Clinical Oncology. 31:e16046-e16046
e16046 Background: Advanced prostate cancer often leads to the development of BM and as a result SREs. Treatment and management of SREs, as well as the underlying disease, influences the patient’s HRQoL and HRU. We evaluated the impact of SREs on H
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9ea9882e72283530292356e38161be32
https://doi.org/10.1200/jco.2013.31.15_suppl.e16046
https://doi.org/10.1200/jco.2013.31.15_suppl.e16046
Autor:
Judith R. Kroep, Carolyn Atchison, Scott M. Schuetze, Silvia Stacchiotti, A. Cioffi, Arthur P. Staddon, Karen Chung, Ira Jacobs, Y. Zhao, A. Lopez Pousa, Charles S. Cleeland, Yi Qian, Andy Powell
Publikováno v:
Journal of Clinical Oncology. 29:10037-10037
10037 Background: GCTB is a rare disease in which osteoclast-like giant cells and mononuclear cells express RANKL, a mediator of osteoclast activation. Symptoms include localized tenderness, swelling, and often severe, intractable pain. Denosumab is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f9b0d7277312b75b1953eae63c508c68
https://doi.org/10.1200/jco.2011.29.15_suppl.10037
https://doi.org/10.1200/jco.2011.29.15_suppl.10037